Moggill, Australia

Paul Francis Alewood

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Moggill, AU (2004 - 2011)
  • Queensland, AU (2015)
  • Pullenvale, AU (2007 - 2020)

Company Filing History:


Years Active: 2004-2020

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Paul Francis Alewood: A Pioneer in Peptide Innovations

Introduction

Paul Francis Alewood, an inventive mind hailing from Moggill, Australia, has made significant contributions to the field of peptide research with a remarkable portfolio of 12 patents. His innovative work primarily focuses on using peptides derived from venom to explore new therapeutic avenues for treating various medical conditions.

Latest Patents

Among his recent inventions, Alewood has developed techniques involving spider venom peptides aimed at modulating sodium channels. This groundbreaking invention presents novel peptides that can inhibit Na1.7 activity, offering a potential pathway for treating or preventing conditions associated with neuropathic, inflammatory, and nociceptive pain. Furthermore, he has introduced the J-superfamily conotoxin peptides, which are short peptides approximately 25 residues long, characterized by two disulfide bonds. These J-conotoxins are derived from the venom of cone snails and hold promise in treating disorders related to voltage-gated ion channels and receptors.

Career Highlights

Throughout his career, Alewood has collaborated with eminent institutions such as The University of Queensland and Xenome Limited. His dedication and innovation have positioned him as a notable figure in the scientific community, contributing to advancements in medicinal chemistry and drug development.

Collaborations

Paul Alewood has worked alongside esteemed colleagues, including Richard James Lewis and Iain Andrew Sharpe. Their combined expertise has facilitated impactful research and development efforts in the realm of peptide technologies.

Conclusion

In conclusion, Paul Francis Alewood represents a significant force in the field of peptide research, showcasing the incredible potential of venom-derived peptides in therapeutic applications. His inventions and collaborative efforts continue to inspire advancements in the treatment of complex medical conditions, solidifying his legacy as a pioneering inventor in the domain of innovations and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…